Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination

Immunogenicity of three recombinant hepatitis B vaccines administered to students in three doses containing half the antigen amount routinely used for adult vaccination

We evaluated the immunogenicity of three recombinant hepatitis B vaccines, one Brazilian (Butang, Instituto Butantan) and two Korean vaccines (Euvax-B, LG Chemical Ltd. and Hepavax-Gene, Greencross Vaccine Corp.), administered intramuscularly to students aged 17 to 19 years in three 10-µg doses (cor...

Full description

Bibliographic Details
Main Authors:	Baldy José Luís da Silveira, Lima Gerson Zanetta de, Morimoto Helena Kaminami, Reiche Edna Maria Vissoci, Matsuo Tiemi, Mattos Edlivia Dias de, Sudan Luci Cristina Pulga
Format:	Article
Language:	English
Published:	Universidade de São Paulo (USP) 2004-01-01
Series:	Revista do Instituto de Medicina Tropical de São Paulo
Subjects:	Recombinant hepatitis B vaccines Immunogenicity Adverse effects
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652004000200009

Similar Items

Immunogenicity of third dose of anti-SARS-CoV-2 vaccine co-administered with influenza vaccine: An open question
by: Pasquale Stefanizzi, et al.
Published: (2022-11-01)

The safety and immunogenicity of vaccines administered to pregnant women living with HIV: a systematic review and meta-analysisResearch in context
by: Eve Nakabembe, et al.
Published: (2024-03-01)

Systematic literature review on the safety and immunogenicity of rotavirus vaccines when co-administered with meningococcal vaccines
by: Priya Pereira, et al.
Published: (2020-11-01)

Sleep and vaccine administration time as factors influencing vaccine immunogenicity
by: Eun Seok Kim, et al.
Published: (2022-03-01)

Factors influencing the immunogenicity of influenza vaccines
by: Simin Wen, et al.
Published: (2021-08-01)

A real-world based study for immunogenicity and safety for three immunization schedules of polio vaccine
by: Li Sun, et al.
Published: (2025-02-01)

Differences in Immunogenicity of Three Different Homo- and Heterologous Vaccination Regimens against SARS-CoV-2
by: Robert Daniel Heinrich Markewitz, et al.
Published: (2022-04-01)

Immunogenicity and safety of a combined DTPa-IPV/Hib vaccine administered as a three-dose primary vaccination course in healthy Korean infants: phase III, randomized study
by: Ki Hwan Kim, et al.
Published: (2019-02-01)

Association between Gut Microbiota Composition and Long-Term Vaccine Immunogenicity following Three Doses of CoronaVac
by: Li-Na Zhang, et al.
Published: (2024-03-01)

Influences of obesity on the immunogenicity of Hepatitis B vaccine
by: Fang Liu, et al.
Published: (2017-05-01)

Immunogenicity of inactivated COVID-19 vaccines at different vaccination intervals
by: Juan Li, et al.
Published: (2021-10-01)

Immunogenicity and safety among laboratory workers vaccinated with Bexsero® vaccine
by: Eva Hong, et al.
Published: (2017-03-01)

Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis
by: Sara Carazo, et al.
Published: (2020-03-01)

Micronutrients to Support Vaccine Immunogenicity and Efficacy
by: Philip C. Calder, et al.
Published: (2022-04-01)

Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
by: Jiawei Xu, et al.
Published: (2024-05-01)

Immunogenicity of three doses of anti-SARS-CoV-2 BNT162b2 vaccine in psoriasis patients treated with biologics
by: Dario Graceffa, et al.
Published: (2022-09-01)

Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews
by: Rodrigo Luiz Carregaro, et al.
Published: (2023-08-01)

Trivalent inactivated influenza vaccine response and immunogenicity assessment after one week and three months in repeatedly vaccinated adults
by: Ahmed Tawfik, et al.
Published: (2023-12-01)

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
by: Dapeng Sun, et al.
Published: (2023-01-01)

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
by: M. M. Baranova, et al.
Published: (2024-06-01)

Safety and immunogenicity of a heterologous booster with an RBD virus-like particle vaccine following two- or three-dose inactivated COVID-19 vaccine
by: Xiaolan Yong, et al.
Published: (2023-12-01)

Comparison of the Immunogenicity and Safety of Three Enhanced Inactivated Poliovirus Vaccines from Different Manufacturers in Healthy Korean Infants: A Prospective Multicenter Study
by: Byung Ok Kwak, et al.
Published: (2020-04-01)

Safety and immunogenicity of Clostridium difficile toxoid vaccine in Japanese adults
by: Osamu Matsuoka, et al.
Published: (2018-02-01)

Immunogenicity and Efficacy Evaluation of Subunit Astrovirus Vaccines
by: Mehdi R.M. Bidokhti, et al.
Published: (2019-08-01)

Immunogenicity and Clinical Efficacy of Influenza Vaccination In Pregnancy
by: Alexander W Kay, et al.
Published: (2015-06-01)

Fatores relacionados à vacinação contra a gripe em idosos: estudo transversal, Cambé, Paraná, Brasil Factors associated with influenza vaccination among the elderly: a cross-sectional study in Cambé, Paraná State, Brazil
by: Eliane Cristina Campos, et al.
Published: (2012-05-01)

Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy
by: Elena Catanzaro, et al.
Published: (2022-06-01)

Intradermal vaccination of adults with three low doses (2 µg) of recombinant hepatitis B vaccine. II. Persistence of immunity and induction of immunologic memory
by: Maria do Carmo M Elisbão, et al.
Published: (2003-12-01)

Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind study
by: Ilaria Galgani, et al.
Published: (2022-05-01)

Seroprevalence for hepatitis E virus (HEV) infection among volunteer blood donors of the Regional Blood Bank of Londrina, State of Paraná , Brazil Soroprevalência da infecção pelo virus da hepatite E (VHE) em candidatos a doadores de sangue voluntários do Hemocentro Regional de Londrina, Londrina, Estado do Paraná, Brasil
by: André Luiz Bortoliero, et al.
Published: (2006-04-01)

Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis
by: Lichen Ouyang, et al.
Published: (2024-12-01)

Impact of Helminth Infections during Pregnancy on Vaccine Immunogenicity in Gabonese Infants
by: Judith Flügge, et al.
Published: (2020-07-01)

Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
by: Lynda Coughlan
Published: (2020-05-01)

Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype Dificuldades no diagnóstico de infecção por HTLV-2 em pacientes com HIV/Aids do Brasil: análise comparativa de ensaios sorológicos e moleculares e detecção de subtipo HTLV-2b
by: Helena Kaminami Morimoto, et al.
Published: (2007-08-01)

Factors affecting the immunogenicity of influenza vaccines in human
by: Qiuyi Xu, et al.
Published: (2023-04-01)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
by: Alycia P. Fratzke, et al.
Published: (2022-05-01)

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
by: Nan-Chang Chiu, et al.
Published: (2018-05-01)

The immunogenicity of PRV ΔgE/TK/UL49.5 three-gene-deleted vaccine in mice
by: Chenmeng Ding, et al.
Published: (2025-02-01)

The Relationship between Immunogenicity and Reactogenicity of Seasonal Influenza Vaccine Using Different Delivery Methods
by: Daniel J. Gromer, et al.
Published: (2024-07-01)

Poxviral promoters for improving the immunogenicity of MVA delivered vaccines
by: Naif Khalaf Alharbi
Published: (2019-01-01)